Disparities in Antiviral Treatment Among Adults With Hepatitis B Cirrhosis: An Analysis of the National Veterans Affairs Cohort.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 37812689.
- Also identified by DOI 10.1093/cid/ciad617.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Timely antiviral therapy is critical in chronic hepatitis B cirrhosis to prevent further liver complications. Among a national cohort of US Veterans with chronic hepatitis B cirrhosis, only 52% were initiated on antiviral therapy; treatment was significantly lower among patients of non-Asian ethnicity, high-risk alcohol use, and in rural settings.
Medical subject headings
- Antiviral Agents
- Hepatitis B, Chronic
- Liver Cirrhosis
- Veterans